Michael M.C. Wong

424 total citations
15 papers, 295 citations indexed

About

Michael M.C. Wong is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Michael M.C. Wong has authored 15 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 4 papers in Clinical Psychology and 4 papers in Cognitive Neuroscience. Recurrent topics in Michael M.C. Wong's work include Schizophrenia research and treatment (8 papers), Family Caregiving in Mental Illness (4 papers) and Functional Brain Connectivity Studies (3 papers). Michael M.C. Wong is often cited by papers focused on Schizophrenia research and treatment (8 papers), Family Caregiving in Mental Illness (4 papers) and Functional Brain Connectivity Studies (3 papers). Michael M.C. Wong collaborates with scholars based in China, Hong Kong and United Kingdom. Michael M.C. Wong's co-authors include Tatia M.C. Lee, Paul Yip, Shihui Han, Pek Lan Khong, Leonard S.W. Li, Nerissa Siu Ping Ho, Chien‐Te Lee, Daniel Walker, Huei Wang and Pierre V. Trân and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychological Medicine and Journal of Affective Disorders.

In The Last Decade

Michael M.C. Wong

15 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael M.C. Wong China 9 126 118 81 61 57 15 295
Jong-Chul Yang South Korea 13 130 1.0× 191 1.6× 109 1.3× 109 1.8× 45 0.8× 52 439
Yasuya Nakato Japan 11 57 0.5× 105 0.9× 149 1.8× 59 1.0× 52 0.9× 17 420
Michael Weightman Australia 9 101 0.8× 69 0.6× 115 1.4× 164 2.7× 63 1.1× 19 409
Denyse O’Leary United Kingdom 2 188 1.5× 66 0.6× 40 0.5× 76 1.2× 38 0.7× 3 323
Valeria Savoja Italy 12 108 0.9× 105 0.9× 95 1.2× 62 1.0× 27 0.5× 29 298
C. Mundt Germany 10 80 0.6× 113 1.0× 119 1.5× 72 1.2× 46 0.8× 23 267
Naotsugu Hirabayashi Japan 11 89 0.7× 194 1.6× 147 1.8× 51 0.8× 26 0.5× 38 367
Muriel Vicent-Gil Spain 11 111 0.9× 103 0.9× 91 1.1× 127 2.1× 25 0.4× 22 340
Karen E. Lythe United Kingdom 10 196 1.6× 70 0.6× 97 1.2× 208 3.4× 91 1.6× 12 411
L. de Haan Netherlands 10 127 1.0× 248 2.1× 99 1.2× 72 1.2× 47 0.8× 20 403

Countries citing papers authored by Michael M.C. Wong

Since Specialization
Citations

This map shows the geographic impact of Michael M.C. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M.C. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M.C. Wong more than expected).

Fields of papers citing papers by Michael M.C. Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M.C. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M.C. Wong. The network helps show where Michael M.C. Wong may publish in the future.

Co-authorship network of co-authors of Michael M.C. Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M.C. Wong. A scholar is included among the top collaborators of Michael M.C. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M.C. Wong. Michael M.C. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lo, William, et al.. (2021). Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence. CNS Neuroscience & Therapeutics. 27(S1). 12–19. 7 indexed citations
2.
Wong, Michael M.C., et al.. (2020). Consensus statements on aripiprazole once-monthly injectable for Hong Kong. Asian Journal of Psychiatry. 54. 102394–102394. 1 indexed citations
3.
Wong, Michael M.C., et al.. (2020). Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong. Internal Medicine Journal. 50(S3). 6–14. 1 indexed citations
4.
Wong, Michael M.C., David Castle, Jun Li, et al.. (2019). Present and future of severe mental illness (SMI) policies: Reflections from an Asia–Pacific Expert Forum series. Psychiatry and Clinical Neurosciences. 74(2). 156–156. 1 indexed citations
5.
Wong, Michael M.C., et al.. (2019). Stress and burden faced by family caregivers of people with schizophrenia and early psychosis in Hong Kong. Internal Medicine Journal. 49(S1). 9–15. 41 indexed citations
6.
Wong, Ka Lam, et al.. (2018). Validation study of the Brief Medication Adherence Scale (BMAS) in patients with schizophrenia and related disorders in Hong Kong. Asian Journal of Psychiatry. 37. 154–160. 5 indexed citations
7.
Chung, Ka‐Fai, et al.. (2018). Experience of stigma among mental health service users in Hong Kong: Are there changes between 2001 and 2017?. International Journal of Social Psychiatry. 65(1). 64–72. 13 indexed citations
8.
Ho, Nerissa Siu Ping, Michael M.C. Wong, & Tatia M.C. Lee. (2016). Neural connectivity of alexithymia: Specific association with major depressive disorder. Journal of Affective Disorders. 193. 362–372. 20 indexed citations
9.
Lo, William, et al.. (2014). Consensus statements on adherence issues in schizophrenia for Hong Kong. Asian Journal of Psychiatry. 12. 163–169. 5 indexed citations
10.
Wong, Michael M.C.. (2011). Management of Bipolar II Disorder. SHILAP Revista de lepidopterología. 33(1). 18–28. 9 indexed citations
11.
Lee, Tatia M.C., et al.. (2009). Selective attention biases of people with depression: Positive and negative priming of depression-related information. Psychiatry Research. 165(3). 241–251. 33 indexed citations
12.
Wong, Michael M.C., et al.. (2009). Gray matter reduction associated with emotion regulation in female outpatients with major depressive disorder: A voxel-based morphometry study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(7). 1184–1190. 56 indexed citations
13.
Wong, Michael M.C., et al.. (2008). Neural correlates of attention biases of people with major depressive disorder: a voxel-based morphometric study. Psychological Medicine. 39(7). 1097–1106. 59 indexed citations
14.
Lee, Chien‐Te, et al.. (2002). Switching to Olanzapine From Previous Antipsychotics. The Journal of Clinical Psychiatry. 63(7). 569–576. 31 indexed citations
15.
Wong, Michael M.C.. (1996). Neuroleptic Malignant Syndrome: Two Cases without Muscle Rigidity. Australian & New Zealand Journal of Psychiatry. 30(3). 415–418. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026